Literature DB >> 29924383

The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: A systematic review and meta-analysis.

Panagiotis Paliogiannis1, Alessandro G Fois2,3, Salvatore Sotgia1, Arduino A Mangoni4, Elisabetta Zinellu3, Pietro Pirina2,3, Ciriaco Carru1, Angelo Zinellu1.   

Abstract

INTRODUCTION: The main white blood cell populations, neutrophils and lymphocytes, are involved in the pathophysiology of chronic obstructive pulmonary disease (COPD). We conducted a systematic review and meta-analysis of studies investigating the relationship between the neutrophil to lymphocyte ratio (NLR, a marker of subclinical inflammation), presence of COPD, and its exacerbations.
METHODS: A comprehensive literature search was conducted in Pubmed, Web of Science and Scopus databases; two investigators independently reviewed suitable studies.
RESULTS: Nine studies, from 247 initially identified, were included in the meta-analysis. Seven studies, in 775 COPD patients with stable disease and 496 healthy controls, showed a significant increase in NLR values in stable COPD (standardised mean difference, SMD, 0.773, 95% CI 0.410-1.136; P < 0.001). Furthermore, in six studies in 527 COPD patients with acute exacerbation and 620 COPD patients with stable disease, NLR values were significantly higher in patients with exacerbations (random effects SMD 0.850, 95% CI 0.549-1.151; P < 0.001).
CONCLUSIONS: Our meta-analysis showed that NLR values are significantly higher in stable COPD patients when compared to healthy individuals, although the magnitude of the difference is reduced after trim and fill adjustment, and in patients with COPD exacerbations when compared to patients with stable disease. Further studies, in larger cohorts, are needed to confirm whether the NLR is a useful tool in discriminating between COPD patients with stable disease, those with acute exacerbations, and subjects without the disease.
© 2018 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  chronic obstructive pulmonary disease; exacerbation; meta-analysis; neutrophil-to-lymphocyte ratio

Mesh:

Year:  2018        PMID: 29924383     DOI: 10.1111/eci.12984

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

Review 1.  Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.

Authors:  Mario Cazzola; Ermanno Puxeddu; Josuel Ora; Paola Rogliani
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

Review 2.  A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Angelo Zinellu; Elisabetta Zinellu; Maria Carmina Pau; Ciriaco Carru; Pietro Pirina; Alessandro G Fois; Arduino A Mangoni
Journal:  J Clin Med       Date:  2022-06-11       Impact factor: 4.964

3.  Increased monocyte level is a risk factor for radiological progression in patients with early fibrotic interstitial lung abnormality.

Authors:  Andrew Achaiah; Paul Lyon; Emily Fraser; Peter Saunders; Rachel Hoyles; Rachel Benamore; Ling-Pei Ho
Journal:  ERJ Open Res       Date:  2022-07-04

4.  Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus.

Authors:  Tuba T Duman; Gulali Aktas; Burcin M Atak; Mehmet Z Kocak; Edip Erkus; Haluk Savli
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

5.  The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.

Authors:  Alessandro G Fois; Panagiotis Paliogiannis; Valentina Scano; Stefania Cau; Sergio Babudieri; Roberto Perra; Giulia Ruzzittu; Elisabetta Zinellu; Pietro Pirina; Ciriaco Carru; Luigi B Arru; Alessandro Fancellu; Michele Mondoni; Arduino A Mangoni; Angelo Zinellu
Journal:  Molecules       Date:  2020-12-04       Impact factor: 4.411

6.  Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease.

Authors:  Yiben Huang; Jianing Wang; Jiamin Shen; Jiedong Ma; Xiaqi Miao; Keke Ding; Bingqian Jiang; Binbin Hu; Fangyi Fu; Lingzhi Huang; Meiying Cao; Xiaodiao Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-26

7.  Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study.

Authors:  Jens Ellingsen; Christer Janson; Kristina Bröms; Karin Lisspers; Björn Ställberg; Marieann Högman; Andrei Malinovschi
Journal:  ERJ Open Res       Date:  2021-12-27

8.  What Are the Most Effective Factors in Determining Future Exacerbations, Morbidity Weight, and Mortality in Patients with COPD Attack?

Authors:  Çağla Koç; Füsun Şahin
Journal:  Medicina (Kaunas)       Date:  2022-01-21       Impact factor: 2.430

9.  The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Xiaozhou Yang; Huimin Yin; Congshu Xiao; Rongkuan Li; Yu Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-29

10.  Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) in Various Respiratory Diseases: A Retrospective Analysis.

Authors:  Milena-Adina Man; Lavinia Davidescu; Nicoleta-Stefania Motoc; Ruxandra-Mioara Rajnoveanu; Cosmina-Ioana Bondor; Carmen-Monica Pop; Claudia Toma
Journal:  Diagnostics (Basel)       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.